- Home
- ELVA vs MDXH Comparison
ELVA vs MDXH Comparison
Compare ELVA & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- MDXH
- Stock Information
- Founded
- ELVA 1996
- MDXH 2003
- Country
- ELVA Canada
- MDXH Belgium
- Employees
- ELVA N/A
- MDXH N/A
- Industry
- ELVA
- MDXH
- Sector
- ELVA
- MDXH
- Exchange
- ELVA Nasdaq
- MDXH Nasdaq
- Market Cap
- ELVA 125.5M
- MDXH 141.1M
- IPO Year
- ELVA N/A
- MDXH 2021
- Fundamental
- Price
- ELVA $6.77
- MDXH $3.90
- Analyst Decision
- ELVA Strong Buy
- MDXH Buy
- Analyst Count
- ELVA 4
- MDXH 1
- Target Price
- ELVA $6.13
- MDXH $6.00
- AVG Volume (30 Days)
- ELVA 516.0K
- MDXH 158.9K
- Earning Date
- ELVA 08-13-2025
- MDXH 11-05-2025
- Dividend Yield
- ELVA N/A
- MDXH N/A
- EPS Growth
- ELVA 58.59
- MDXH N/A
- EPS
- ELVA 0.03
- MDXH N/A
- Revenue
- ELVA $54,875,000.00
- MDXH $98,953,000.00
- Revenue This Year
- ELVA $46.40
- MDXH $24.40
- Revenue Next Year
- ELVA $46.08
- MDXH $22.29
- P/E Ratio
- ELVA $248.75
- MDXH N/A
- Revenue Growth
- ELVA 10.88
- MDXH 22.56
- 52 Week Low
- ELVA $1.73
- MDXH $1.35
- 52 Week High
- ELVA $7.08
- MDXH $3.91
- Technical
- Relative Strength Index (RSI)
- ELVA 70.59
- MDXH 68.73
- Support Level
- ELVA $5.76
- MDXH $3.46
- Resistance Level
- ELVA $6.23
- MDXH $3.80
- Average True Range (ATR)
- ELVA 0.41
- MDXH 0.17
- MACD
- ELVA 0.02
- MDXH -0.01
- Stochastic Oscillator
- ELVA 77.37
- MDXH 94.74
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.